Literature DB >> 10561165

Signaling inhibitors in the clinic: new agents and new challenges.

G Hudes.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10561165     DOI： 10.1200/JCO.1999.17.4.1093

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Novel tricyclic indeno[2,1-d]pyrimidines with dual antiangiogenic and cytotoxic activities as potent antitumor agents.

Authors:  Aleem Gangjee; Ying Zhao; Michael A Ihnat; Jessica E Thorpe; Lora C Bailey-Downs; Roy L Kisliuk
Journal:  Bioorg Med Chem       Date:  2012-06-06       Impact factor: 3.641

Review 2.  Signaling inhibitors in the treatment of prostate cancer.

Authors:  Gary R Hudes
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

3.  Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin.

Authors:  D Liu; O C Hutchinson; S Osman; P Price; P Workman; E O Aboagye
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.